Published in Diagn Pathol on June 24, 2015
Mutations of the BRAF gene in human cancer. Nature (2002) 65.42
A genetic model for colorectal tumorigenesis. Cell (1990) 44.37
Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A (2005) 15.46
CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet (2006) 13.63
Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med (2005) 9.39
Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature (2002) 7.46
DNA methylation profiles in monozygotic and dizygotic twins. Nat Genet (2009) 5.99
Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology (2008) 5.19
Tobacco-smoking-related differential DNA methylation: 27K discovery and replication. Am J Hum Genet (2011) 5.18
Inheritance of a cancer-associated MLH1 germ-line epimutation. N Engl J Med (2007) 4.87
Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Hum Mol Genet (2001) 3.15
KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer. Lancet Oncol (2010) 3.12
DNA methylation decreases in aging but not in immortal cells. Science (1983) 2.67
Recruitment of DNA methyltransferase I to DNA repair sites. Proc Natl Acad Sci U S A (2005) 2.50
Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst (2010) 2.38
DNA damage, homology-directed repair, and DNA methylation. PLoS Genet (2007) 2.29
Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique (2003) 2.25
Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening. Cancer Epidemiol Biomarkers Prev (2008) 2.12
Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers. Cancer Res (2004) 2.10
Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential? Cancer Epidemiol Biomarkers Prev (2002) 2.08
Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer. Cancer Res (2003) 2.03
Improved fecal DNA test for colorectal cancer screening. Clin Gastroenterol Hepatol (2006) 1.99
Immunohistochemical analysis reveals high frequency of PMS2 defects in colorectal cancer. Gastroenterology (2005) 1.96
Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann Oncol (2011) 1.84
BRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genes. Oncogene (2005) 1.62
Nutritional epigenetics: impact of folate deficiency on DNA methylation and colon cancer susceptibility. J Nutr (2005) 1.59
Adherence to Mediterranean diet and risk of cancer: a systematic review and meta-analysis of observational studies. Int J Cancer (2014) 1.54
Transcriptional control of the DNA methyltransferases is altered in aging and neoplastically-transformed human fibroblasts. Mol Cell Biochem (2003) 1.45
Epigenetic drift in aging identical twins. Proc Natl Acad Sci U S A (2005) 1.42
Aging, methylation and cancer. Histol Histopathol (2000) 1.40
Hyperhomocysteinemia in chronic alcoholism: correlation with folate, vitamin B-12, and vitamin B-6 status. Am J Clin Nutr (1996) 1.38
Distinct BRAF (V600E) and KRAS mutations in high microsatellite instability sporadic colorectal cancer in African Americans. Clin Cancer Res (2009) 1.35
Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR. Clin Cancer Res (2007) 1.33
Sex differences in epidemiological, clinical and pathological characteristics of colorectal cancer. J Gastroenterol Hepatol (2009) 1.25
Mutation analysis of BRAF exon 15 and KRAS codons 12 and 13 in Moroccan patients with colorectal cancer. Int J Biol Markers (2010) 1.13
Use of DNA from human stools to detect aberrant CpG island methylation of genes implicated in colorectal cancer. Cancer Epidemiol Biomarkers Prev (2004) 1.12
KRAS and BRAF mutations in patients with rectal cancer treated with preoperative chemoradiotherapy. Radiother Oncol (2009) 1.09
Tumorigenesis in colorectal tumors from patients with hereditary non-polyposis colorectal cancer. Hum Genet (1997) 1.06
Mediterranean diet and colorectal cancer risk: results from a European cohort. Eur J Epidemiol (2013) 1.06
MLH1 promoter methylation frequency in colorectal cancer patients and related clinicopathological and molecular features. PLoS One (2013) 0.94
Cancer risks for the relatives of colorectal cancer cases with a methylated MLH1 promoter region: data from the Colorectal Cancer Family Registry. Cancer Prev Res (Phila) (2011) 0.88
Clinical significance of microsatellite instability in colorectal cancer. Langenbecks Arch Surg (2013) 0.87
Somatic molecular changes and histo-pathological features of colorectal cancer in Tunisia. World J Gastroenterol (2013) 0.78
Digestive cancers in Morocco: Fez-Boulemane region. Pan Afr Med J (2012) 0.76
Adherence to a Mediterranean diet in Morocco and its correlates: cross-sectional analysis of a sample of the adult Moroccan population. BMC Public Health (2012) 0.76